PeptideStack
5.2kquestions
20kanswers
220users

What happens to retatrutide after two weeks at 2–8 °C in solution?

Asked 13 Oct 2025Modified 10 months agoViewed 6.5k times
20

Setup, so nobody has to ask: retatrutide · two weeks · 2–8 °C.

The empirical answer seems settled. The explanation does not.

If the honest answer is that nobody knows, I would rather hear that than a plausible story.

Is the standard explanation correct, and if so, what is the evidence for it?

peptide-stability
peptide-stability

The chemistry of peptide degradation: deamidation, oxidation, hydrolysis, aggregation and fibrillation, and how temperature, pH, ionic strength,…

832 questions
storage
storage

Storage conditions and their evidence base: minus twenty degrees for powder, refrigerated for solution, protection from light, and what the…

646 questions
shelf-life
shelf-life

How long a preparation remains within specification: labelled expiry for a sealed lyophilised vial, beyond-use dating after reconstitution, and…

301 questions
shareeditfollowflag
SI
askedsample_id17k2713 Oct 2025
Does this hold at lower concentrations, or does adsorption dominate? – gradient_slope 6 months ago
8Worth flagging that this changed in 2025, so older answers on the site are out of date. – nkem_obiora 4 months ago
add a comment

No answers yet

This question has not been answered. It has been viewed 6.5k times, which suggests the question is of interest and the answer is not obvious. If you can answer it with a source or a worked calculation, it will be read. See how to ask and answer.
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.